Qualitative platelet dysfunction following cancer chemotherapy: a case report

Area of Science:

• Oncology
• Hematology
• Pharmacology

Background:

• Cancer chemotherapy regimens can have diverse side effects.
• Platelet dysfunction is a potential complication of certain chemotherapeutic agents.
• Understanding treatment-related toxicities is crucial for patient management.

Observation:

• A case of qualitative platelet dysfunction was observed.
• The dysfunction occurred following a specific cancer chemotherapy regimen.
• The patient experienced a bleeding diathesis.

Findings:

• Chemotherapy induced not only a numerical reduction in platelets but also functional defects.
• Platelet function suppression was confirmed in the patient.
• The specific regimen included cyclophosphamide, methotrexate, and 5-fluorouracil.

Implications:

• This case underscores the importance of monitoring platelet function during chemotherapy.
• Functional platelet defects can contribute to bleeding complications in cancer patients.
• Further research into chemotherapy-induced platelet dysfunction is warranted.